A184 REPURPOSING DRUGS FOR SPLEEN TYROSINE KINASE (SYK) PEDIATRIC PATIENTS USING HIGH-THROUGHPUT SCREENING

por Chau, S, Jardine, S, Guo, C, Warner, N, Muise, A
Publicado 2022

A105 CHRONIC DIARRHOEA AND ELEVATED LIVER ENZYMES IN A PATIENT WITH AUTOIMMUNE POLYGLANDULAR SYNDROME TYPE 1

por Yodoshi, T, Valdes, D G, Siddiqui, I, Ngan, B, Muise, A, Gould, M J
Publicado 2023

A42 HETEROGENEITY IN EFFICACY AND SAFETY ENDPOINTS FOR PEDIATRIC CLINICAL TRIALS IN INFLAMMATORY BOWEL DISEASE: A NEED FOR HARMONIZATION

por Crowley, E, Turner, D, Ma, C, Nguyen, T, McKay, H, Schneider, R, Silverberg, A, Muise, A, Feagan, B, Griffiths, A, Jairath, V
Publicado 2022

NOX1 loss-of-function genetic variants in patients with inflammatory bowel disease

por Schwerd, T., Bryant, R. V., Pandey, S., Capitani, M., Meran, L., Cazier, J.-B., Jung, J., Mondal, K., Parkes, M., Mathew, CG, Fiedler, K., McCarthy, D. J., Sullivan, PB, Rodrigues, A., Travis, SPL, Moore, C., Sambrook, J., Ouwehand, W. H., Roberts, D. J., Danesh, J., Russell, R. K., Wilson, D. C., Kelsen, J. R., Cornall, R., Denson, L. A., Kugathasan, S., Knaus, U. G., Goncalves Serra, E., Anderson, C. A., Duerr, R. H., McGovern, D. P. B., Cho, J., Powrie, F., Li, V. S. W., Muise, A. M., Uhlig, H. H.
Publicado 2017